Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Puromycin dihydrochloride: Technical Guide for Selection & T

    2026-06-02

    Puromycin dihydrochloride: Technical Application Guide

    What This Product Solves

    Puromycin dihydrochloride is a well-established aminonucleoside antibiotic widely used in molecular biology laboratories as a selective agent and a probe for translation process studies. Its primary utility lies in the efficient selection and maintenance of stable cell lines expressing the pac gene, which confers resistance via puromycin N-acetyltransferase. By inhibiting protein synthesis through competitive binding at the ribosomal A site, puromycin dihydrochloride supports rapid elimination of non-transfected or non-transduced cells in both prokaryotic and eukaryotic systems. Additionally, the compound is valuable for dissecting ribosome function and cellular translation dynamics, and has been applied as an autophagic inducer in animal models. For researchers seeking a robust selection marker for pac gene or a precise tool for translation process study, puromycin dihydrochloride provides a reproducible and well-characterized solution.

    Protocol Parameters

    • Selection concentration in mammalian cells: 0.5–10 μg/mL | Use for selection of pac gene-expressing mammalian cell lines | Reflects typical IC50 range; titration by cell type recommended | product information
    • Maximal solubility: ≥99.4 mg/mL in water | Stock solution preparation | Enables high-concentration stocks for efficient workflow | product information
    • Working concentration range: 0–200 μg/mL | Experimental treatments up to 72 hours | Suitable for rapid cell killing and mechanistic translation or ribosome function analysis | product information
    • Storage temperature: –20°C (powder or stock solution) | Preserves compound integrity for several months | Avoids degradation; long-term solution storage not advised | product information
    • Solvent compatibility: DMSO (≥27.2 mg/mL), ethanol (≥3.27 mg/mL with sonication), water (≥99.4 mg/mL) | Stock preparation flexibility | Match solvent to downstream application and stability requirements | product information

    Workflow Setup and QC Checklist

    • Cell line validation: Confirm pac gene expression prior to puromycin application to avoid unnecessary loss of valuable cultures. When establishing new lines, perform kill curves to titrate the minimum effective selection concentration for each cell type.
    • Stock preparation: Dissolve puromycin dihydrochloride in sterile water to prepare concentrated stocks (e.g., 10 mg/mL). Filter-sterilize and aliquot to minimize freeze-thaw cycles. For applications requiring alternative solvents, consider DMSO or ethanol as per solubility limits and compatibility.
    • Storage and handling: Store powder and solutions at –20°C. Avoid repeated freeze-thaw and extended storage of aqueous solutions; prepare fresh working solutions as needed for critical experiments.
    • Selection protocol: Add puromycin to cultures at empirically determined concentrations. Monitor cell viability daily and replace medium with fresh drug every 2–3 days during initial selection. For robust maintenance, continue selection at the lowest effective concentration.
    • QC readouts: Include parallel non-resistant controls to verify selection efficiency. Assess protein synthesis inhibition by immunoblotting or metabolic labeling if translation process study is intended.

    Common Failure Modes and Fixes

    • Low selection stringency: If non-pac-expressing cells survive, verify drug potency and correct concentration. Prepare a fresh stock from powder and re-titrate selection levels.
    • Excessive cell death in resistant lines: Over-selection can occur if concentrations exceed optimal values for a given cell type. Reduce drug level and confirm pac gene integrity.
    • Precipitation or turbidity: Incomplete dissolution may occur if using suboptimal solvents or cold solutions. Warm solution gently and use appropriate solvent as per solubility data.
    • Loss of activity after storage: Degradation is possible with repeated freeze-thaw or long-term solution storage. Prepare aliquots for single-use and avoid storing diluted solutions for extended periods.
    • Inconsistent results across lots: Always note lot numbers and repeat kill curves when switching product batches or suppliers.

    Scope and Limitations

    Puromycin dihydrochloride is best suited for rapid selection of cell lines engineered to express the pac gene, and for acute studies of translation or ribosome function. It acts as an effective autophagic inducer in some animal models and can be used across a range of organisms provided the selection marker is present. However, the compound is not recommended for applications requiring long-term solution stability, nor for organisms or systems lacking the pac selection marker. Extended exposure (>72 hours) or use at concentrations exceeding recommended ranges may result in off-target effects or excessive cytotoxicity. Always refer to Puromycin dihydrochloride product information and perform empirical optimization as required.

    For advanced troubleshooting strategies and protocol optimization, see Puromycin dihydrochloride: Precision Selection & Translational Insights, which discusses kill curve establishment and QC in diverse cell systems. Additional mechanistic and technical perspectives are available in Puromycin dihydrochloride: Next-Gen Applications in Translational Biology, with workflow-specific advice for translation process and ribosome function analysis.

    Conclusion

    Puromycin dihydrochloride remains a cornerstone for selection marker workflows and translational investigations in molecular biology. By adhering to validated protocol parameters, maintaining rigorous quality control, and recognizing scope limitations, researchers can ensure reproducibility and efficiency in applications ranging from stable cell line generation to detailed ribosome function analysis. For further product details, refer to the official APExBIO Puromycin dihydrochloride page.